![]() Press Release Distribution |
Filter News Show All ResultsNews By Country
News By Tag R D ![]() Related Tags AMSO
Big Pharma Biotech Biotechnology Chesterford Cnpc Development Industries Market Report Mwe Oil Oil Shale Pharmaceutical Reports Research Research And Development Shale Technology VKG Ypf
| r d Latest News+ XML/RSSBy Insight Pharma Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics Report By Insight Pharma Late Phase Market Dynamics Report - This report contains the following three sections: Late Phase Trends and Market Sizing, Service Provider Dynamics and Decision Making for Late Phase Studies Insight Pharma Affiliated Reports Collection Announces Royalty Financing Terms and Agreements Report By Insight Pharma Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics Report By Insight Pharma Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report By Insight Pharma Respiratory Distress Syndrome – Pipeline Review Report - This report provides information on the therapeutic development for Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. By Insight Pharma Diabetes Care Devices Global Market Briefing to 2016 Report - This report provides market landscape, competitive landscape and market trends information the diabetes care devices market. By Insight Pharma Competitor Analysis: HIV Small Molecule Therapeutics Report - This report includes a compilation of marketed products and currently active projects in research and development of HIV Small Molecule Therapeutics. By Insight Pharma Clinical Development Staff Quality & Resourcing Models Report By Insight Pharma Biopharma Outsourcing Performance Report This report examines the outsourcing relationship from the CRO's perspective and benchmarks many sponsor companies' outsourcing operations and practices. By Insight Pharma Biosimilars: Surveying the Market Landscape Report - This report reviews all aspects of biosimilar production, from manufacturing and marketing to the regulatory landscape. By Sarah Brereton, Limewash Media & Design Ltd The Park team and tenants at Chesterford Research Park put their best feet forward on Friday to do their bit for Sports Relief. By Lean Frontiers A number of lean manufacturing authors and practitioners are scheduled to speak at an Indianapolis event May 1-3. By Limewash Media & Design Ltd Dodson Jones join Savills as joint agents for Chesterford Research Park By Insight Pharma Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity Report By Insight Pharma Antibody-Drug Conjugates 2011 – real breakthrough still to come: a Technology, Stakeholder and R&D Pipeline Analysis Report By Insight Pharma Reports Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations By Michael Herbstritt Recognising that corrosion protection is a basic requirement for electric actuators, AUMA has made major investment in upgrading its procedures for coating components. By Leyton On Thursday 29th March, R&D tax credit specialists Leyton will be in the Pillo Hotel, Headford Road, Galway at 9am to host an R&D Tax Credit seminar with a difference. By alliantgroup alliantgroup’s Managing Director Jeremy Fingeret, J.D., was invited to join a prestigious group of tax legal advisors at the American Bar Association’s Section of Taxation Midyear Meeting in San Diego on February 17, 2012. By Sarah Brereton, Limewash Media & Design Ltd A delegation from Saudi Arabia visited Chesterford Research Park to better understand successful research park development. Chesterford was chosen as an excellent example of best practice in research park development and management. By MedTech Senator Kirsten Gillibrand toured Welch Allyn last Friday and addressed members of MedTech--the hub of Upstate New York's Bio/Med industry--who voiced concerns about R&D tax credits, investors and higher education. Sharda Motor Industries Limited, leading tier- 1 supplier to auto majors opens R&D centre at Chennai By Srinvisan Raju, Widerange communication- PR agency • support to auto makers & engine manufacturers to design, develop and manufacture a broad range of auto ancillaries • Value engineering and value analysis will reduce cost and enhance performance • Working in tandem with Ricardo and Sango By Leyton Leyton, the Research and Development Tax Credit specialists will brief Plastic Ireland members on the R&D Tax Credit scheme and the impact recent budget changes will have on Irish business By EXHEAT Ltd With a large number of exciting projects in the pipeline our new R&D facilities are crucial for EXHEAT to meet changing market requirements and to introduce new technologies into the current product range. More than 100 Leading Organizations to Convene in San Francisco Next Month for R&D Informatics Event By Cambridge Healthtech Institute 100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012. By Visiongain Petrochemical infrastructure development is driven by growth in newly industrialised nations turning to the production of polymer products, and those which have a high demand for fertilisers and fuel additives. By ValueNotes Recently published research shows a major shift in global pharmaceutical companies outsourcing core research and development (R&D) services such as drug development and clinical trials through strategic third-party collaborative partnerships. By Cambridge Healthtech Institute CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco. By Clair Lin Domestic pesticide market continues to be depressed. Overcapacity is still the main reason to drag domestic pesticide industry in downturn. By Randall Eickhoff, C.P.A. The reauthorization of the SBIR and STTR programs are a significant win for American small business and affirm the government's commitment to supporting growth through innovation. By Cambridge Healthtech Institute Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum. alliantgroup Adds to Its Team of Advisors to Champion the Cause for U.S. Businesses and Job Creation By alliantgroup Former U.S. Congressman Rick Lazio from New York joins tax specialty firm, alliantgroup, as Director By Clair Lin Professor Fuliang Chen from Plant Protection Institute of CAAS will present a speech on EC formulations policy, taking place on March 9th, 2012, at Ramada Plaza Gateway Shanghai, China. By Visiongain Over the next decade, global demand for oil & gas is set to rapidly increase as rising populations and economic growth help to drive the industry. This will create a need for additional oil & gas infrastructure to be constructed. By Chroma ATE Inc. Multiplying engineers resources with minimal investment, Chroma ATE announced its new 3110 Hybrid Handler for the Semiconductor Industry offering a compact footprint, fully automated device handing, multi bin sorting and remote capabilities. By Visiongain Oil demand remains high despite the uncertainty in the global economy of late. Discoveries of light easy-to-produce crude oil are decreasing, with less than 10 billion barrels a year added to reserves over the last ten years. By Sara Murphy - Leyton - www.leyton.com/ie Budget 2012 announced that the Research and Development (“R&D”) Tax Credit scheme would be altered. Leyton provide key analysis on these changes. By Cambridge Healthtech Institute Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA. By ASTRI in Hong Kong Two distinguished researchers from Hong Kong Applied Science and Technology Research Institute (ASTRI), Dr Wang Keh-chung and Dr Wu Enboa were conferred the title of Fellow by IEEE. 'Report predicts world antibacterial drugs market will reach $43.8bn in 2016' says Visiongain report By Visiongain A new report by visiongain, a London-based business information company, predicts that world revenues for antibacterial drugs will reach $43.81bn in 2016. By Visiongain A new report by visiongain predicts that revenues for disease-modifying treatments for multiple sclerosis (MS) will rise to $15.8bn annually in 2015. That analysis appears in Multiple Sclerosis Treatment: World Drug Market 2012-2022. By Visiongain CCS technology consists of capturing carbon dioxide (CO2) directly from industrial or utility plants and storing it in secure reservoirs, typically depleted oil and gas fields and saline aquifers. The global medical device contract manufacturing revenues will reach $95.7bn in 2021 says Visiongain By Visiongain A new report by visiongain, a London-based business information provider, predicts that the global medical device contract manufacturing revenues will reach $95.7bn in 2021. By TCG Lifesciences Limited TCG Lifesciences Limited (TCGLS) has announced that it has entered into a strategic agreement with JSW Lifesciences (JSW), a full services EU based CRO, to strengthen its R&D offerings in the area of Central Nervous System (CNS). By Visiongain The oil & gas virtual reality training and simulation market is being driven by a combination of increasing demand for oil & gas, the retirement of the baby boomer generation, improving technologies, and increasing safety concerns. By Visiongain A combination of high oil prices, oversupply of natural gas, increasing global energy demands, and improving extraction technologies is creating a renewed interest in the gas to liquids market. By Jenny Toole, Marketing Director Paradigm Partners has Selected MFG.com as a Strategic Partner With The Goal of Further Educating the Manufacturing Industry about Lucrative Tax Incentives. By Clair Lin A free webinar on China’s mancozeb was successfully held by CCM at 16:30 (GMT+8, Beijing Time) October 27, 2011. By Arrowhead Publishers and Conferences Drug repositioning offers the possibility of breathing new life into pharmaceutical R&D. By recycling drug data, repositioning promises to boost production, accelerate and derisk R&D, and enhance product life-cycle management. Frost & Sullivan: Global CRO Market Revitalized Post Recession with Robust Revenue and Volume Growth By Frost & Sullivan Cost and productivity benefits ensure greater traction for CRO services | ||||||||||||||||||||||